ZYUS Life Sciences
Manufacturing · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
407 Downey Rd 204, Saskatoon, Saskatchew...Phone Number
(888) 651-9987Website
www.zyus.comRevenue
<$5 MillionStock Symbol
ZYUSIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About ZYUS Life Sciences
ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates for medical and adult recreational. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2a clinical trial for the treatment of chronic pain in adults caused due to musculoskeletal injuries, arthritis, and cancer. It operates in Canada, the United States, Australia, and the European Union. ZYUS Life Sciences Corporation was founded in 2018 and is headquartered in Saskatoon, Canada.Explore more
ZYUS Life Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ZYUS Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if ZYUS Life Sciences is spiking on competitors!
Product Launch: Get notified when ZYUS Life Sciences launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at ZYUS Life Sciences
Funding: Get notified immidiatlly once ZYUS Life Sciences has new funding data
Earning: See what the market has to say on ZYUS Life Sciences recently announced quarterly report
Click to see if ZYUS Life Sciences had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
ZYUS Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if ZYUS Life Sciences has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to ZYUS Life Sciences
Compare insights from companies similar to ZYUS Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ZYUS Life Sciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ZYUS Life Sciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ZYUS Life Sciences.
ZYUS Life Sciences financials insights
Gather financial insights about ZYUS Life Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Stock/Share Issuance
$73K
2026
Multiple Rounds
$695K
ZYUS Life Sciences Tech Stack
A closer look at the technologies used by ZYUS Life Sciences
See more technologies
Most Recent Scoops
Funding
ZYUS Life Sciences has secured approximately $106,000 in Debt funding. Investors were not disclosed.
Funding
Funding
ZYUS Life Sciences has secured approximately $191,000 in Debt funding. Investors were not disclosed.
Funding
Project
Product Development, Product Management, Intellectual Property, Legal Affairs, Pharmaceuticals
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
ZYUS Life Sciences News & Media
ZYUS Life Sciences Announces Closing of Debt Financing - Newswire.ca
/CNW/ -- ZYUS Life Sciences Corporation ("ZYUS" and or the "Company") (TSXV: ZYUS), a clinical stage life sciences company focused on the development and...ZYUS Life Sciences Corporation Provides Liquidity and Working Capital Update and ...
/CNW/ -- ZYUS Life Sciences Corporation ("ZYUS" and or the "Company") (TSXV: ZYUS), a clinical-stage life sciences company focused on the development and...ZYUS Life Sciences Corporation Announces Completion of Secured Loan Financing
/CNW/ -- ZYUS Life Sciences Corporation (the "Company") (TSXV: ZYUS), a clinical-stage life sciences company focused on the development and commercialization...ZYUS Life Sciences Corporation Announces Closing of Eighth Tranche of Secured Loan ...
ZYUS Life Sciences Corporation (the "Company") (TSXV: ZYUS), a clinical-stage life sciences company focused on the development and commercialization of novel non-opioid drug candidates for pain management, is pleased to announce that its wholly-owned subsidiary, ZYUS Life Sciences Inc. ("ZYUS Inc."), has closed an eighth tranche (the "Eighth Tranche") of a secured loan financing (the "Secured Loan") on August 13, 2026 with certain lenders (the "Lenders"), including certain insiders of the Compan
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding ZYUS Life Sciences
Sign Up For FreeTo access detailed company insights
ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates for medical and adult recreational. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2a clinical trial for the treatment of chronic pain in adults caused due to musc... Read More
